Home / Ophthalmology
Ophthalmology
| 2 min read
HitGen announces second drug discovery collaboration of the year
| 3 min read
Researchers use RNA sequencing to investigate spermatogonial stem cells and tackle infertility
| 3 min read
Biogen announces agreement to acquire Nightstar Therapeutics to establish clinical pipeline of gene therapy candidates in ophthalmology
| 3 min read
GenSight Biologics announces publication of positive safety data in JAMA Ophthalmology from Phase 1/2 trial of GS010 for Leber Hereditary Optic Neuropathy
| 3 min read
Clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy; 1 in 4 subjects showed better BCVA from baseline in their GS010-treated eye than in their sham-treated eye, and better change in low-contrast sensitivity in their GS010-treated eye than in their sham-treated eye
| 4 min read
Study suggests genetic commonalities between cardiovascular disease and Alzheimer's disease in some individuals
| 4 min read
Evidence supports serum neurofilament light as useful biomarker; Biogen and Siemens to develop blood test
| 3 min read
Year two results consistent with previously announced key secondary endpoint data on retinal fluid showing superior reductions versus aflibercept; visual gains shown in year one with brolucizumab were maintained in year two
| 3 min read
Independent long-term study highlights effectiveness of iCAD’s Xoft Electronic Brachytherapy system for early-stage breast cancer treatment
| 2 min read
Positive results validate Eyenovia’s piezo-print technology for topical eye treatment as company prepares for Phase III trials in progressive myopia, CACG and mydriasis
| 3 min read
Aura Biosciences presents interim Phase 1b/2 data at the American Society of Retina Specialists annual meeting
| 3 min read
GenSight’s GS010 improves vision in Phase 3 trial of patients with rare genetic disease
